Could a blood pressure drug curb alcohol cravings?
NCT ID NCT04135846
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a drug that blocks alpha-1 receptors can help people with alcohol use disorder drink less and feel less craving. About 184 adults who want to cut back or quit drinking will take the drug or a placebo and report their drinking and cravings. The goal is to see if targeting stress-related brain pathways can reduce alcohol use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER (AUD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Brown University
RECRUITINGProvidence, Rhode Island, 20923, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Zapping the brain to fight alcoholism: a new hope?
- Rewiring the brain to fight alcohol cravings?
- Can cash rewards and a breathalyzer app help people stay sober?
- Could a brain hormone curb alcohol cravings and lift depression at the same time?
- Mindfulness may help tame alcohol cravings by reconnecting body and mind